Systemic Hypertension · 2022 · 20 citations · 153 references
PharmacyNephrologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyRenal PharmacotherapyBlood Pressure ManagementCardiovascular DiseaseChronic Kidney DiseaseRenal DiseaseCardiovascular Risk DetectionCardiovascular Risk ManagementConsensusPharmacologic Uric Acid LoweringTreatment Of Asymptomatic HyperuricemiaUric Acid-lowering Therapy
After 3 years since the release of the first consensus on the management of patients with hyperuricemia and high cardiovascular risk. During this time, new data appeared that confirm the importance of uric acid control as a risk factor for cardiovascular complications and allow optimizing the algorithm for managing such patients. Studies since the first consensus emerged have identified new hyperuricemia thresholds for cardiovascular risk. The present consensus regulates the prescription of urate-lowering therapy depending on the severity of the detected hyperuricemia. However, although a large body of data demonstrates a positive effect of urate-lowering therapy on the cardiovascular prognosis, there is a need for additional evidence to support the treatment of asymptomatic hyperuricemia.
153
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams, Giuseppe Mancia, Wilko Spiering et al. · European Heart Journal · 2018 · 10.4K citations · Full text
B N Ames, Richard Cathcart, Elizabeth Schwiers et al. · Proceedings of the National Academy of Sciences · 1981 · 2.9K citations · Full text
Dinesh Khanna, John FitzGerald, Puja Khanna et al. · Arthritis Care & Research · 2012 · 1.5K citations · Full text